{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T06:35:55Z","timestamp":1776753355375,"version":"3.51.2"},"reference-count":25,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T00:00:00Z","timestamp":1776729600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82401649"],"award-info":[{"award-number":["82401649"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82230040"],"award-info":[{"award-number":["82230040"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82071415"],"award-info":[{"award-number":["82071415"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81873778"],"award-info":[{"award-number":["81873778"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2024M752018"],"award-info":[{"award-number":["2024M752018"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Aging Neurosci."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      The\n                      <jats:italic>C9ORF72<\/jats:italic>\n                      repeat expansion is the most common genetic cause of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). While neurofilament light chain (NEFL) is an established biomarker of neuroaxonal damage, its specific dose-response relationship with the\n                      <jats:italic>C9ORF72<\/jats:italic>\n                      expansion and its potential role beyond a passive bystander require systematic investigation. We performed a proteome-wide screen to identify plasma proteins linked to the\n                      <jats:italic>C9ORF72<\/jats:italic>\n                      expansion and evaluated their predictive value for motor neuron disease (MND).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We utilized whole-genome sequencing and plasma proteomics from the UK Biobank, analyzing 106 individuals with\n                      <jats:italic>C9ORF72<\/jats:italic>\n                      expansions (defined as &amp;gt;30 repeats) and 212 age- and sex-matched controls. We screened ~3,000 proteins for associations with the continuous repeat count. The top candidate was evaluated using restricted cubic splines (RCS) to assess non-linearity and threshold effects. Its ability to independently predict MND risk was tested using regression models and a machine learning approach.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Our unbiased screen identified NEFL as the sole protein significantly associated with the\n                      <jats:italic>C9ORF72<\/jats:italic>\n                      repeat count (FDR-adjusted\n                      <jats:italic>P<\/jats:italic>\n                      = 8.39 \u00d7 10\n                      <jats:sup>\u22124<\/jats:sup>\n                      ). NEFL levels demonstrated a step-wise increase with expansion size, which followed a stable linear trajectory across the repeat spectrum (\n                      <jats:italic>P<\/jats:italic>\n                      <jats:sub>non \u2212 linear<\/jats:sub>\n                      = 0.4435). Elevated NEFL independently predicted MND risk (OR = 2.42; HR = 2.90), even after adjusting for the\n                      <jats:italic>C9ORF72<\/jats:italic>\n                      repeat count. Our predictive model, combining NEFL and repeat count, achieved an AUC of 0.941 with 100% sensitivity. These findings align with emerging evidence that secreted NEFL may actively modulate neuroinflammation.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      NEFL emerges as a robust and specific plasma biomarker for\n                      <jats:italic>C9ORF72<\/jats:italic>\n                      -related neurodegeneration. Its strong linear association with repeat burden and independent predictive power, contextualized within its potential role in immune activation, suggest that NEFL is deeply integrated into the\n                      <jats:italic>C9ORF72<\/jats:italic>\n                      pathological landscape. These findings support NEFL-based screening and monitoring strategies for early intervention in\n                      <jats:italic>C9ORF72<\/jats:italic>\n                      carriers.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fnagi.2026.1792887","type":"journal-article","created":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T05:35:45Z","timestamp":1776749745000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Systematic proteomics reveals plasma NEFL as a robust predictor and pathological associate in C9ORF72-related neurodegeneration"],"prefix":"10.3389","volume":"18","author":[{"given":"Zhen","family":"Hu","sequence":"first","affiliation":[{"name":"Department of Neurology, Ruijin Hospital Luwan Branch, Shanghai Jiao Tong University School of Medicine","place":["Shanghai, China"]},{"name":"Department of Neurology and Institute of Neurology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine","place":["Shanghai, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing-jin","family":"Wan","sequence":"additional","affiliation":[{"name":"Department of Surgery, Renji Hospital, Shanghai Jiao Tong University School of Medicine","place":["Shanghai, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qin-qin","family":"Yan","sequence":"additional","affiliation":[{"name":"Department of Radiology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine","place":["Shanghai, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Fan","sequence":"additional","affiliation":[{"name":"Department of Neurology and Institute of Neurology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine","place":["Shanghai, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Neurology and Institute of Neurology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine","place":["Shanghai, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/s41582-018-0047-2","article-title":"C9orf72-mediated ALS and FTD: multiple pathways to disease","volume":"14","author":"Balendra","year":"2018","journal-title":"Nat. Rev. Neurol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1038\/s41587-024-02382-1","article-title":"Comprehensive genome analysis and variant detection at scale using DRAGEN","volume":"43","author":"Behera","year":"2025","journal-title":"Nat. Biotechnol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s41586-018-0579-z","article-title":"The UK Biobank resource with deep phenotyping and genomic data","volume":"562","author":"Bycroft","year":"2018","journal-title":"Nature"},{"key":"B4","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.tins.2013.04.010","article-title":"Current insights into the C9orf72 repeat expansion diseases of the FTLD\/ALS spectrum","volume":"36","author":"Cruts","year":"2013","journal-title":"Trends Neurosci."},{"key":"B5","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1001\/jamapsychiatry.2025.2429","article-title":"Neurofilament light chain and differentiation of behavioral variant frontotemporal dementia from psychiatric disorders: a systematic review","volume":"83","author":"Davydow","year":"2026","journal-title":"JAMA Psychiatry"},{"key":"B6","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.neuron.2011.09.011","article-title":"Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS","volume":"72","author":"DeJesus-Hernandez","year":"2011","journal-title":"Neuron"},{"key":"B7","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.cell.2024.10.045","article-title":"Atlas of the plasma proteome in health and disease in 53,026 adults","volume":"188","author":"Deng","year":"2025","journal-title":"Cell"},{"key":"B8","doi-asserted-by":"publisher","first-page":"4754","DOI":"10.1093\/bioinformatics\/btz431","article-title":"ExpansionHunter: a sequence-graph-based tool to analyze variation in short tandem repeat regions","volume":"35","author":"Dolzhenko","year":"2019","journal-title":"Bioinformatics"},{"key":"B9","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/s43587-023-00565-0","article-title":"Plasma proteomic profiles predict future dementia in healthy adults","volume":"4","author":"Guo","year":"2024","journal-title":"Nat. Aging"},{"key":"B10","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1093\/brain\/awr354","article-title":"Clinical and pathological features of familial frontotemporal dementia caused by C9ORF72 mutation on chromosome 9p","volume":"135","author":"Hsiung","year":"2012","journal-title":"Brain J. Neurol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1002\/acn3.51078","article-title":"Longitudinal biomarkers in amyotrophic lateral sclerosis","volume":"7","author":"Huang","year":"2020","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/S1474-4422(21)00462-2","article-title":"Whole genome sequencing for the diagnosis of neurological repeat expansion disorders in the UK: a retrospective diagnostic accuracy and prospective clinical validation study","volume":"21","author":"Iba\u00f1ez","year":"2022","journal-title":"Lancet Neurol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1007\/s00401-011-0913-0","article-title":"Molecular pathology and genetic advances in amyotrophic lateral sclerosis: an emerging molecular pathway and the significance of glial pathology","volume":"122","author":"Ince","year":"2011","journal-title":"Acta Neuropathol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"2404","DOI":"10.1093\/bioinformatics\/btac137","article-title":"BWA-MEME: BWA-MEM emulated with a machine learning approach","volume":"38","author":"Jung","year":"2022","journal-title":"Bioinformatics"},{"key":"B15","doi-asserted-by":"publisher","first-page":"115382","DOI":"10.1016\/j.celrep.2025.115382","article-title":"Secreted neurofilament light chain after neuronal damage induces myeloid cell activation and neuroinflammation","volume":"44","author":"Kahn","year":"2025","journal-title":"Cell Rep."},{"key":"B16","doi-asserted-by":"publisher","first-page":"2589","DOI":"10.1038\/s41588-024-02042-9","article-title":"DRAGEN optimizes genomic variant detection","volume":"56","author":"Li","year":"2024","journal-title":"Nat. Genet."},{"key":"B17","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1080\/17582024.2024.2421738","article-title":"Neurofilament light chain: a biomarker at the crossroads of clarity and confusion for gene-directed therapies","volume":"14","author":"MC","year":"2024","journal-title":"Neurodegener. Dis. Manage."},{"key":"B18","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.neuron.2011.09.010","article-title":"A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD","volume":"72","author":"Renton","year":"2011","journal-title":"Neuron"},{"key":"B19","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s13024-025-00851-y","article-title":"RNA-binding proteins in ALS and FTD: from pathogenic mechanisms to therapeutic insights","volume":"20","author":"Rummens","year":"2025","journal-title":"Mol. Neurodegener."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1136\/jnnp-2021-326914","article-title":"Plasma NfL levels and longitudinal change rates in C9orf72 and GRN-associated diseases: from tailored references to clinical applications","volume":"92","author":"Saracino","year":"2021","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-023-06592-6","article-title":"Genetic regulation of the human plasma proteome in 54,306 UK Biobank participants","author":"Sun","year":"2022","journal-title":"bioRxiv"},{"key":"B22","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1002\/acn3.70001","article-title":"ALS plasma biomarkers reveal neurofilament and pTau correlate with disease onset and progression","volume":"12","author":"Thomas","year":"2025","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"B23","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/s41586-025-09272-9","article-title":"Whole-genome sequencing of 490,640 UK Biobank participants","volume":"645","year":"2025","journal-title":"Nature"},{"key":"B24","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/978-1-4939-8876-1_21","article-title":"Bioinformatics analysis of whole exome sequencing data","volume":"1881","author":"Ulintz","year":"2019","journal-title":"Methods Mol. Biol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1097\/WCO.0000000000001411","article-title":"Neurochemical biomarkers of amyotrophic lateral sclerosis: recent developments","volume":"38","author":"Verde","year":"2025","journal-title":"Curr. Opin. Neurol."}],"container-title":["Frontiers in Aging Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnagi.2026.1792887\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T05:35:47Z","timestamp":1776749747000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnagi.2026.1792887\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,21]]},"references-count":25,"alternative-id":["10.3389\/fnagi.2026.1792887"],"URL":"https:\/\/doi.org\/10.3389\/fnagi.2026.1792887","relation":{},"ISSN":["1663-4365"],"issn-type":[{"value":"1663-4365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,21]]},"article-number":"1792887"}}